INTRODUCTION

Since t h e f i r s t r e p o r t o f a p a t i e n t with abnormal t y r o s i n e metabolism by Medes (18) i n 1932, s e v e r a l d i f f e r e n t d i s o r d e r s o f t y r o s i n e o x i d a t i o n have been described ( 2 5 ) . The commonest i s t r a n s i e n t neonatal tyrosinemia due t o p a r t i a l impairment of p-hydroxyphenylpyruvic (p-HPPA) hydroxylase a c t i v i t y vhich converts p-HPPA t o liomogentisic a c i d i n the catabolism of t y r o s i n e . Hypertyrosinemia r e s u l t s and a number of unusual t y r o s i n e m e t a b o l i t e s a r e farmed v h i c h , t o g e t h e r with t y r o s i n e , appear i n t h e u r i n e ( t y r o s y l u r i a ) . These include p-HPPA. p-hydroxyphenyl l a c t i c a c i d (p-HPLA) and p-hydroxyphenylacetic a c i d (p-HPAA).
There are t h r e e i n t e r -r e l a t e d causes of hypertyrosinemia i n the newborn: 1. dimi n i s h e d amounts of p-HPPA hydroxylase apoenryme i n the l i v e r , 2. high d i e t a r y i n t a k e of t y r o s i n e , and 3.
low i n t a k e of d i e t a r y a s c o r b i c a c i d (20).
Two types of n a n t r a n s i e n t hypertyrosinemia have been described:
Type I o r h e r e d i t a r y tyrosinemia. This m a n i f e s t s i n an a c u t e form with h e p a t i c and r e n a l dysfunction v i t h i n t h e f i r s t s i x months of l i f e and i s usua l l y r a p i d l y f a t a l in u n t r e a t e d p a t i e n t s . o r i n a more chronic form with nodul a r h e p a t i c c i r r h o s i s , nephropethy causing t h e Fanconi syndrorae. f a i l u r e t o t h r i v e and hypoglycemia (14). Although t h e a c t i v i t y of p-HPPA hydroxylase i s impaired, t h e cause of t h i s type of tyrosinemia i s unclear:
The p a t i e n t s benef i t from s t r i n g e n t r e s t r i c t i o n of d i e t a r y t y r o s i n e i n t a k e (25).
2. Type I 1 or hypertyrosinemia Oregon type o r oculo-cutaneous t y r o s i n o s i s . We know of 9 reported p a t i e n t s who seem t o conform t a t h i s type (1.2.6.8.10, 15.24,29). There i s some phenotypic v a r i a b i l i t y b u t n o s t have had mental ret a r d a t i o n . k e r a t o s i s plantopalmaris corneal dystrophy (Richner -Hanhart syndrome). In two p a t i e n t s c y t o s o l t y r o s i n e aminotransferase (TAT) d e f i c i e n c y i n l i v e r vas reported (2.5.15).
The d i s o r d e r runs a non-progressive course v i t h high plasma t y r o s i n e l e v e l s and t y r o s y l u r i a . R e s t r i c t i o n of d i e t a r y t y r o s i n e i n t a k e r e v e r s e s t h e biochemical abnormality and improves t h e s k i n and eye l e s i o n s (1. 6.8.15.24,29) .
Other reported c a s e s of hypertyrasinemia. i n c l u d i n g t h a t of Medes, showed the c l i n i c a l f e a t u r e s of n e i t h e r Type I n o r Type I 1 (17.18.27) . W e d e s c r i b e a p a t i e n t v i t h s e i z u r e s and d-velopmental delay, but with no o t h e r c l i n i c a l a b n o r m a l i t i e s , i n whom c y t o s o l TAT a c t i v i t y has been shorn t o be abnormally low i n s k i n f i b r o b l a s t s .
CASE REPORT
A g i r l , born a f t e r a normal pregnancy and d e l i v e r y , appeared normal a t b i r t h ; weight 2.53 Kg. The p a r e n t s , l i v i n g i n a remote a r e a i n northwestern Ontario, a r e n a t i v e Canadian Indians and, a s f a r a s i s known, t h e r e i s no cons a n g u i n i t y . Their plasma t y r o s i n e l e v e l s v e r e normal. A second c h i l d , e boy. was born a year a f t e r t h e b i r t h of t h e p a t i e n t and i s normal. He does not have tyrosinemia.
When f i v e months o l d . the p a t i e n t had g a s t r o e n t e r i t i s with dehydration and generalized s e i z u r e s . Two months l a t e r t h e r e were f u r t h e r s e i z u r e s , mainly confined t o t h e r i g h t s i d e of t h e body and a s s o c i a t e d with a f e b r i l e upper r e s p i r a t o r y i n f e c t i o n . Despite a n t i c o n v u l s a n t therapy, a f e b r i l e r i g h t s i d e d s e i z u r e s continued i n t e r m i t t e n t l y and a t age 84 months she was admitted t o t h e C h i l d r e n ' s H o s p i t a l .
Physical examination was normal; weight 7.7 Kg (10th p e r c e n t i l e ) , l e n g t h 70 cm (50th p e r c e n t i l e ) . There was no evidence of l i v e r o r bone d i s e a s e and t h e r e v e r e no s k i n o r eye a b n o r m a l i t i e s . F u l l n e u r o l o g i c a l i n v e s t i g a t i o n , i n c l u d i n g s k u l l radiographs, b r a i n scan and electroencephalogram, was normal. The u r i n e gave p o s i t i v e d i n i t r o p h e n y l h y d r a r i n e and n i t r o s o n a p h t h o l t e s t s (21) and showed l a r g e amounts of t y r o s i n e on t h i n l a y e r chromatography. Plasma t y r o s i n e l e v e l was 0 . 9 1~ moleslml and t y r o s i n e m e t a b o l i t e s were l a t e r demons t r a t e d i n u r i n e (see belaw). Treatment with a s c o r b i c a c i d (500 mg d a i l y by mouth) and pyridoxine HC1 (250 mg d a i l y by m u c h ) had no c o n s i s t e n t e f f e c t upon blood t y r o s i n e l e v e l s (Fig. 1 ) . At 50 weeks of age she v a s t e s t e d on t h e Yale Developmental Schedules. Her o v e r a l l performance v a s a t 44 weeks with many successes a t 48 weeks. She t h u s appeared t o f a l l i n t o t h e lov-normal range.
Anticonvulsant therapy v i t h phenobarbital and d i l a n t i n was maintained and t h e r e v e r e no f u r t h e r s e i z u r e s . There was n o t h i n g s u g g e s t i n g t h e need f o r d i e t a r y treatment a t t h i s time and she was allowed home a t 14 months of age.
During t h e n e x t 1 0 months s h e remained w e l l except f o r two b r i e f a f e b r i l e grand ma1 s e i z u r e s ; growth continued t o be normal. When re-assessed a t 24 months, the blood t y r o s i n e l e v e l v a s s t i l l g r e a t l y e l e v a t e d ( Fig.1 ) and a p o s i t i v e u r i n e dinitrophenylhydrazine t e s t i n d i c a t e d t h e continued presence of k e t a a c i d s . Physical examination v a s normal b u t s h e was hyperactive and h e r developmental q u o t i e n t was now a s s e s s e d as only 75%. The electroencephalogram was s t i l l normal. Because of t h i s d e t e r i o r a t i o n i n development a d i e t low i n phenylalanine (25-31 mg/Kg) and low i n t y r o s i n e (20-27 mg/Kg) was begun. Blood t y r o s i n e l e v e l s during the n e x t year a r e shovn i n Figure 1 .
When l a s t seen a t age t h r e e y e a r s she shoved s i g n i f i c a n t delay i n a l l areas of development --motor and adaptive s k i l l s a t t h e t h i r t y month l e v e l , language and s o c i a l s k i l l s a t about t h e 12 month l e v e l .
89t Methods I Amino a c i d s i n plasma and u r i n e v e r e determined with a Perkin Elmer KLA-5 amino a c i d a n a l y s e r . Plasma samples were deproteinized with s u l f o s a l i c y l i c a c i d p r i o r t o a n a l y s i s (25). Organic a c i d s were i d e n t i f i e d and q u a n t i t a t e d gas chromoatography -mass speetrometry-computer techniques ( 7 ) . (courtesy o Dr. 0.A. Mamer of Montreal). Tissue Preparation: Skin f i b r o b l a s t s v e r e grown from s s k i n biopsy taken, a f t e r informed consent, from the p a t i e n t a t age 12 months. Control f i b r o b l a c u l t u r e s were taken from 4 age-matched normal s u b j e c t s . Betveen 2 x lo5 and 4 x 105 c e l l s from each f i b r o b l a s t l i n e were seeded i n t o two s e p a r a t e 100 m m d i s h e s (Falcon P l a s t i c s Oxnard, Ce) c o n t a i n i n g 5 ml o f McCoy's 5 s t i s s u e c u l cure medium (Grand I s l a n d B i o l o g i c a l Co.), supplemented v i t h 5% human cord serum (Microbiological Associates. Bethesda. MD) and a n t i b i o t i c s ( p e n i c i l l i n streptomycin-fungicellin).
The d i s h e s vere then incubated a t 37.5" i n a watl jacketed i n c u b a t o r w i t h 100% humid atmosphere of 5% C02 i n a i r . The c e l l s va subcultured twice a week. Sixteen f i b r o b l a s t c u l t u r e s each from the p a t i e n t and age-matched c o n t r o l s v e r e used i n t h e s e experiments. The f i b r o b l a r t s us, were a l l o f low passage numbers. C e l l s were r e l e a s e d from t h e d i s h e s f o r treatment with 0.05% t r y p s i n in Dulbecco's phosphatP b u f f e r e d s a l i n e (pH 7.2) f o r 7 -1 0 mi". a t 37O. Trypsl i z a t i o n was stopped by t h e a d d i t i o n of a 5-fold excess of t h e growth medium. A sample was taken f o r c e l l enumeration. C e l l s were c o l l e c t e d by c e n t r i f u g at i o n . washed t h r i c e i n 0.2 M phosphate b u f f e r (pH 7.2) and 15 x l o 6 c e l l s f r l each c u l t u r e were homogenized with 4 volumes of cold 0.14 M KC1 by 6 s t r o k e s t h e t i g h t p e s t l e of a Dotmce homogenizer. S u b c e l l u l a r f r a c t i o n a t i o n by d i f f e e n t i a l c e n t r i f u g a t i o n was c a r r i e d o u t e s s e n t i a l l y according t o Tulkens e t a1 (26). The 18.000 x g p e l l e t of t h e p o s t n u c l e a r f r a c t i o n was used as t h e mitochondial f r a c t i o n and the high speed (105.00 x g ) s u p e r n a t a n t a s t h e cyta s 0 1 i c f r a c t i o n . The p r o t e i n content of t h i s f r a c t i o n u s u a l l y was 500-600 p~ per m l . Assay of Tyrasine Aminotransferase: (L-tyrosine: 2 o x o g l u t a r a t e aminotransf e r a s e . E-C 2.6.1.5):
This enzyme was assayed i n t h e c y t o s o l i c f r a c t i o n by tvo d i f f e r e n t methods, the p-hydroxybenzaldehyde method o f Diamondstone ( 3 ) and t h e method of Rosen e t a 1 (23) based on t h e formation o f a coloured comp l e x between p-HPPA and ammonium molybdate. In some experiments t h e Diamond. scone method and i n o t h e r s t h e Rosen method were used. Bath methods gnve col parable assay r e s u l t s . The enzyme a c t i v i t y was assayed a t four d i f f e r e n t con c e n t r a t i o n s of pyridoxal phosphate (PLP) added t o t h e incubation medium -0 , 1.2.10 and 20 mH. In i n i t i a l experiments (Table I and 
o r t h r e e hours o r passed through a Sephadex G 2 5 column and e l u t e d with t h e same b u f f e r t o remove frea pyridoxal phosphate of t h e c y t o s o l . The mitachandrial enzyme vaa assayed on by t h e method of Diamondstone. ( 3 ) The lower l i m i t o f s e n s i t i v i t y of t h i s procedure i s t h e formation of 0.2 p mole p-HPPA. Assay of p-Hydroxyphenylpyruvate Hydroxylase (p-hydroxyphenylpyruvaLes. a s c o r b a t e : 0, oxidoreductase ( h v d r o x y l a t i n~) . ED 1.14.2.2):
The c o l a r i m e t r I a s s a y method i f Fellman e t a l . ( 4 ) va; used: I Results Amino Acids and Phenolic Acids i n Plasma and Urine: Figure 1 shows plasma t y r o s i n e l e v e l s from age 11 -36 months i n r e l a t i o n t o vitamin and d i e t a r y treatment. Concentrations of o t h e r plasma amino a c i d s , i n c l u d i n g methionine and phenylalanine, shoved no c o n s i s t e n t abnormality. Urine t y r o s i n e l e v e l s before t h e i n s t i t u t i o n of d i e t a r y treatment ranged from 13.4 -27.6 mMllOOg (normal < 4 . 0 ) . Plasma p-HPLA v a s 0.9 mgll (normally undetectable (8)). Urir o r n a n i c a c i d s ( a l n c r e a t i n i n e ) were: P-HPPA 0.8 ( t r a c e ) . D-HPLA 1 . 6 (< 0.01) p -H~~ 0.5 (< 0101). Normal values (8) are i n parentheses.
Growth and v i a b i l i t y o f t h e c u l t u r e d f i b r o b l a s t s : F i b r o b l a s t s from t h e p a t i e n t and matched c o n t r o l s were c u l t u r e d f a r s e v e r a l passaaes in presence
&=Coy's 5 a t i s s u e c u l t u r e medium supplemented v i t h 5 % human cord serum. Thid medium contained 0.5 mg p e r l i t e r of pyridoxine and 0.5 mg p e r l i t e r o f p y r i doxal. Thus, f i b r o b l a s t s from both sources were c u l t u r e d i n a medium contai. i n g adequate c o n c e n t r a t i o n of vitamin B6. There vas no d i f f e r e n c e between t t tvo f i b r o b l a s t c u l t u r e s i n regard t o t h e time required t o achieve confluency a s w e l l a s i n t h e v i a b i l i t y of t h e c e l l s . Cytoaolic TAT: The r e s u l t s a r e given i n Table I 
. I n t h e absence of PLP adde t o the incubation medium t h e r e v a s a small amount of TAT a c t i v i t y with both the p a t i e n t and c o n t r o l f i b r o b l a s t s . I n c r e a s i n g the PLP c o n c e n t r a t i o n o f COT t r o l f i b r o b l a s t s from zero t o 20 mM l e d t o a 15-fold i n c r e a s e in enzyme a c t i x i t y . A s i m i l a r i n c r e a s e i n PLP c o n c e n t r a t i o n o f t h e p a t i e n t ' s f i b r o b l n s t s ha approximately 20 percent t h e a c t i v i t y of c o n t r o l s . When t h e c o n c e n t r a t i o n ob PLP was increased t o 50 mM t h e r e was an i n h i b i t i o n o f enzyme a c t i v i t y only i n c o n t r o l c u l t u r e s . At a l l the c o n c e n t r a t i o n s of PLP t e s t e d . the f i b r o b l a s t c u l t u r e s derived from t h e p a t i e n t showed much lower a c t i v i t y of TAT. Fig. 2 shows t h e c y t o s o l i c TAT a c t i v i t y of f i b r o b l a s t s from p a t i e n t and con t r o l s p l o t t e d a g a i n s t t h e c o n c e n t r a t i o n of t h e c y t o s o l i c p r o t e i n with PLP con c e n t r a t i o n s of 1 . 2 and 10.0 mM. Although t h e r e was l i n e a r i t y i n the refiponsq P Y R I D O X I N E
I Y I T a H ! * I C -
Figure 1: Plasma t y r o s i n e l e v e l s of t h e p a t i e n t i n r e l a t i o n t o treatment given. The h o r i z o n t a l i n t e r r u p t e d l i n e i n d i c a t e s t h e mean l e v e l s f o r normal i n f a n t s (2.17). Mean + standard deviation of 7 separate experiments in each of which the cosubstrate was included in concentration range of 0-20 mM. The reaction mixture contained. in a total volume of 3.2 m1,the following: 2.6 ml of 0.2 M potassium phosphate buffer, pH 7.2 containing 19.2 p moles of L-tyrosine; 0.1 ml of a buffered dithiocarbamate; and 0.2 ml of appropriate dilution of the fresh enzyme. The mixture was equilibrated at 37O and the reaction was started by the addition of 0.1 ml of a buffered solution of 0.3 M c-keotglutarate. The reaction was stopped after 10 min. by the addition of 0.2 ml of 10 N NaOH and the tubes shaken imediately. After 30 mi". at room temperature the solutions vere read at 331 mM against a zero time control prepared by the addition of NaOH before the rrketo~lutarate.
I CYTOSOLIC TYROSINE AMINOTRANSFERASE (TAT) OF CULTURED FIBROBLASTS
Mean + standard deviation of four experiments in each of which the cosubstrate was included in concentration range 0-20 mM. The reaction mixture contained in a total volume of 2.9 ml the following: 1.9 ml of 0.2 M potassium phosphate buffer. pH 7.3 containing 30 p moles of diethyl dithiocarbamate and 0.16 M sucrose; 0.3 ml of the cytosol and 0.1 ml of PLP solution (0-20mM). The mixture was equilibrated at 38O for 3 min. and the reaction started by the addition of 0.6 orl of 0.01 Il tyrosine. The mixture was incubated for 10 min. at 380 and reaction stopped by the addition of 0.3 ml of 100% tricholoracetic acid. The mixture was filtered on a Whatman 81 filter paper. To 1 ml of the filtrate 2 ml of the color reagent (12 ml of 3% amonium molybdate in 5 N HCL plus 20 ml of 1% KHz PO4 plus 32 ml distilled water) was added. Absorbance at 850 m was read after 1 hour of color development.
p < 0.005 with respect to controls.
at all protein concentrations tested the enryme activity of patient's fibroblasts was about fifth of the activity of the control fibroblasts. In these experiments undialyzed cytosolic fractions used would have contributed to the final concentration of pyridoxal phosphate in the TAT assay medium.
In further experiments a dialysate or a sephadex C-25 filtrate of the cytosol of fibroblasts fram the patient or age matched control was used to assay for TAT. Both cytosolic enzyme preparations. free from endogenous pyridoxal phosphate, had very little measurable TAT activity. Addition of pyridoxal phosphate to the enzyme preparation resulted in measurable TAT activity which was linear with respect to protein included in the assay (Fig. 3) . The enryme fram control fibroblasts showed a linear response to the incubation time up to 30 minutes, after which it plateaued. The enzyw preparation from the pltient's fibroblasts gave s linear response to the incubation time up to 40 minutes. The data presented in Fig. 3 are for a 5 minute assay. The enzyme from the patient's fibroblast was much less active, being about 20 percent of the activity of the enzyme from control fibroblasts. The profile of enryme activity was the same regardless of the use of a dialyzed or undialyzed cytosol in measuring enryme activity.
The kinetic characteristics of the cytosolic TAT of the two fibroblasts were determined using Lineweaver Burke plots. The results are compared in Table  11 . There was oo significant difference between the enzyme from either source in terms of the Vmax and the Km for tyrosine. These values are in the range reported for TAT from other sources. Vmax values ranping from 1.35 to 5.0 m p moles product formed per min per mg protein have been reported (9.22). The reported values for the Km for tyrosine are in the range 1.2 to 1.7 x M (9,11.19,28).
However there is a significant difference between the enzyme from the ~atient's fibroblasts and control in regard to the Km for pyridoxal phosphate. The Km for pyridoxal phosphate of the control enzyme is in the range reported for enzyme from rat liver (16). The Km of the enzyme from the patient's fibroblasts for pyridoxal phosphate was almost two orders of magnitude more than that far the enzyme from control fibroblasts. Thus the enzyme from the ~atient's fibroblasts has a significantly decreased affinity for pyridoxal phosphate. 
DISCUSSION
TAT and p-HPPA hydroxylase are the first two enzymes in the oxidative pathway of tyrosine. PLP is a cosubstrate for TAT and ascorbic acid a cosubstrate for p-HPPA hydroxylase. TAT exists in at least two forms: a solu--- Enzyme preparation from fibroblast cultures and the assay of TAT by the method of Diamondstone (3) are described "Methods".
